Botulinum toxin A injections provide relief from tics in patients with Tourette syndrome.
The Scientist Staff
Aug 29, 2000
NEW YORK, Aug 29 (Praxis Press). Botulinum toxin A (BTX) is an effective treatment for an increasing number of conditions characterized by abnormal muscle contractions. However, its safety and efficacy in the treatment of tics in patients with Tourette syndrome (TS) has not been well studied. To evaluate BTX for this purpose, Kwak and colleagues studied 35 patients (30 male, 5 female) by injecting them with BTX in the sites of their most problematic tics. They evaluated the response to BTX based on a 0 to 4 clinical rating scale (0, no improvement, to 4, marked improvement in both severity and function). In addition, questionnaires were administered to evaluate patients' impressions of overall efficacy and degree of benefit with premonitory sensations. They found that 21 out of 25 patients with premonitory sensations derived marked relief of these symptoms. They also found that the mean peak-effect response in 35...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!